Alkem Laboratories share news, announcements and annual reports
NSE: ALKEMBSE: 539523Pharmaceuticals & BiotechnologyMid Cap
Alkem Laboratories Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2015
Last close ₹5,155.00up ₹41.50 (0.81%)BSE ₹5,150.00
Share price at the NSE close on 2 Nov 2026. Previous close ₹5,113.50.
2 Nov: open ₹5,100.00, high ₹5,155.00, low ₹5,044.00
52-week range of traded prices to 2 Nov 2026
₹4,811.00Low, 22 Oct 2026₹5,933.50High, 13 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹61,636 Cr164th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 28.57
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.46
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.03%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 16.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 16.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.11
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,00,19050.3% delivered
Alkem Laboratories share news and announcements
794 announcements, routine notices left out, newest first. Page 12 of 16.
Nov 2020
6 Nov · Board meeting
Oct 2020
28 Oct · Board meeting
Aug 2020
7 Aug · Results
7 Aug · Board meeting
Jul 2020
27 Jul · Board meeting
Jun 2020
25 Jun · Annual Disclosure
5 Jun · Results
5 Jun · Board meeting
May 2020
Apr 2020
Mar 2020
17 Mar · News Verification
The exchange asked on 16 Mar 2020
5 Mar · Meeting
Feb 2020
7 Feb · Management
7 Feb · Management
7 Feb · Results
7 Feb · Board meeting
Jan 2020
29 Jan · Corporate action
Dec 2019
Nov 2019
11 Nov · Updates
11 Nov · Results
11 Nov · Board meeting
Oct 2019
18 Oct · Board meeting